| Anti-spike protein assays to determine SARS-CoV-2 antibody levels: a head-to-head comparison of five quantitative assays T Perkmann, N Perkmann-Nagele, T Koller, P Mucher, A Radakovics, ... Microbiology spectrum 9 (1), 10.1128/spectrum. 00247-21, 2021 | 175 | 2021 |
| Side-by-side comparison of three fully automated SARS-CoV-2 antibody assays with a focus on specificity T Perkmann, N Perkmann-Nagele, MK Breyer, R Breyer-Kohansal, ... Clinical Chemistry 66 (11), 1405-1413, 2020 | 132 | 2020 |
| Seven day pre-analytical stability of serum and plasma neurofilament light chain P Altmann, M Ponleitner, PS Rommer, H Haslacher, P Mucher, ... Scientific reports 11 (1), 11034, 2021 | 29 | 2021 |
| Reduced sensitivity of commercial spike-specific antibody assays after primary infection with the SARS-CoV-2 omicron variant DN Springer, T Perkmann, CM Jani, P Mucher, K Prüger, R Marculescu, ... Microbiology Spectrum 10 (5), e02129-22, 2022 | 21 | 2022 |
| The comparability of anti-spike SARS-CoV-2 antibody tests is time-dependent: a prospective observational study T Perkmann, P Mucher, N Perkmann-Nagele, A Radakovics, M Repl, ... Microbiology Spectrum 10 (1), e01402-21, 2022 | 20 | 2022 |
| Basal myokine levels are associated with quality of life and depressed mood in older adults P Mucher, D Batmyagmar, T Perkmann, M Repl, A Radakovics, ... Psychophysiology 58 (5), e13799, 2021 | 17 | 2021 |
| Initial SARS-CoV-2 vaccination response can predict booster response for BNT162b2 but not for AZD1222 T Perkmann, N Perkmann-Nagele, P Mucher, A Radakovics, M Repl, ... International Journal of Infectious Diseases 110, 309-313, 2021 | 12 | 2021 |
| Serum antibody response to BNT162b2 after natural SARS‐CoV‐2 infection T Perkmann, N Perkmann‐Nagele, T Koller, P Mucher, A Radakovics, ... European Journal of Clinical Investigation 51 (11), e13632, 2021 | 11 | 2021 |
| Spike protein antibodies mediate the apparent correlation between SARS-CoV-2 nucleocapsid antibodies and neutralization test results T Perkmann, T Koller, N Perkmann-Nagele, M Klausberger, M Duerkop, ... Microbiology Spectrum 9 (1), 10.1128/spectrum. 00218-21, 2021 | 11 | 2021 |
| Comparison of five Anti-SARS-CoV-2 antibody assays across three doses of BNT162b2 reveals insufficient standardization of SARS-CoV-2 serology T Perkmann, P Mucher, D Ösze, A Müller, N Perkmann-Nagele, T Koller, ... Journal of Clinical Virology 158, 105345, 2023 | 8 | 2023 |
| Increasing both specificity and sensitivity of SARS-CoV-2 antibody tests by using an adaptive orthogonal testing approach T Perkmann, T Koller, N Perkmann-Nagele, M Ozsvar-Kozma, D Eyre, ... | 6* | 2020 |
| Delays during PBMC isolation have a moderate effect on yield, but severly compromise cell viability T Golke, P Mucher, P Schmidt, A Radakovics, M Repl, P Hofer, ... Clinical Chemistry and Laboratory Medicine (CCLM) 60 (5), 701-706, 2022 | 4 | 2022 |
| The comparability of Anti-Spike SARS-CoV-2 antibody tests is time-dependent: a prospective observational study T Perkmann, P Mucher, N Perkmann-Nagele, A Radakovics, M Repl, ... medRxiv, 2021.08. 26.21262426, 2021 | 2 | 2021 |
| Multiparametric Prediction Models for Coronavirus Disease 2019 Vaccine Selection: Results of a Comparative Population-Based Cohort Study D Sieghart, CA Hana, H Haslacher, T Perkmann, LX Heinz, C Fedrizzi, ... Clinical Infectious Diseases 76 (5), 816-823, 2023 | 1 | 2023 |
| Preanalytical stability of SARS-CoV-2 anti-nucleocapsid antibodies T Niedrist, L Kriegl, CJ Zurl, F Schmidt, N Perkmann-Nagele, P Mucher, ... Clinical Chemistry and Laboratory Medicine (CCLM) 61 (2), 332-338, 2023 | 1 | 2023 |
| Sequential activation of DNA viruses by the RNA virus SARS-CoV-2 in patients with long COVID syndrome M Gyongyosi, E Hasimbegovic, D Lukovic, K Zlabinger, A Spannbauer, ... European Heart Journal 44 (Supplement_2), ehad655. 1823, 2023 | | 2023 |
| Effect of monovalent COVID-19 vaccines on viral interference between SARS-CoV-2 and several DNA viruses in patients with long-COVID syndrome M Gyöngyösi, D Lukovic, J Mester-Tonczar, K Zlabinger, P Einzinger, ... npj Vaccines 8 (1), 145, 2023 | | 2023 |
| SARS-CoV-2 infections in “less visible” hospital staff: The roles and safety of environmental services and allied health professionals S Jensen, M Traugott, D Ramazanova, H Haslacher, P Mucher, ... Journal of Infection and Public Health 16 (9), 1379-1385, 2023 | | 2023 |
| Breakthrough infections with SARS-CoV-2 omicron efficiently boost antibodies from previous BNT162b2 vaccinations T Perkmann, DN Springer, P Mucher, M Wolzt, L Weseslindtner, ... Journal of Clinical Virology Plus 3 (3), 100157, 2023 | | 2023 |
| Small extracellular vesicles are released ex vivo from platelets into serum and from residual blood cells into stored plasma MS Małys, MC Köller, K Papp, C Aigner, D Dioso, P Mucher, H Schachner, ... Journal of Extracellular Biology 2 (5), e88, 2023 | | 2023 |
